Eduard R. Virshke

Eduard R. Virshke

Auto-generated profile, based on publicly available information

Eduard R. Virshke

N.N. Blokhin National Medical Research Center of Oncology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2018 in Oncopediatrics
Verified
Journal Article
Open access
PDF file
ТUТatiana L. Ushakova
Тatiana L. Ushakova
IТIgor A. Тrofimov
Igor A. Тrofimov
ОGОlga V. Gorovtsova
Оlga V. Gorovtsova
АYАndrey A. Yarovoy
Аndrey A. Yarovoy
SSSvetlana V. Saakyan
Svetlana V. Saakyan
ВЯВ. А. Яровая
В. А. Яровая
Background.Retinoblastoma (RB) is a life threatening cancer disease. A breakthrough in the treatment of children with RB is associated with the improvement of conservative treatment that was administered in at least one of the two tumor-affected eyes in most bilateral cases, that was chemotherapy both systemic and local (selective intra-arterial and intravitreal) in most cases combined with laser therapy, cryotherapy, or brachytherapy. The development of such techniques as local chemotherapy is focused on preservation of visual functions, reducing the number of enucleations and radiotherapy (RT) course. The success of the healing of RB is closely associated with a multidisciplinary approach to diagnosis and treatment, as well as specialized longterm follow-up clinical examination.Objective.eye and vision preservation against large intraocular tumors with different growth types and localization without the course of remote radiation therapy was the main purpose.Methods.In the period from September 2012 to January 2016, the study enrolled 45 patients with RB when at least one eye had intraocular tumor spread corresponding to the group C or D. According to the ABC international classification, patients have a relatively good prognosis for organ-preserving treatment. 4 of 18 children with bilateral RB had undergone primary enucleation of worse eye the worst eye, group E; 49 (77.8%) of the 63 affected eyes had features for groups C and D. In this study, no patient received local chemotherapy initially, only after prior systemic chemotherapy. Selective intra-arterial chemotherapy (SIAC) was applied to 41 patients (45 eyes; mean course number was 2), and 32 patients (34 eyes) had undergone intravitreal chemo therapy (IViC) (mean course number was 2). Focal therapy and local chemotherapy were the main methods of treatment for progression (new lesions on the retina) in 8 (16.3%) of 49 eyes with tumors of group C (n=1) and D (n=7); the relapse in 14 of 49 (new lesions on the retina) in eyes with tumors of group C (n=5) and D (n=6) and (new lesions on the retina and the vitreous) in eyes with tumors of group D (n=3) (28.5%), and stabilization of disease n=23 (46.9%). We should note that 2 patients underwent repeated course of in case of systemic chemotherapy, 1 patient — a Gamma Knife procedure due to registered disease stabilization, progression or relapse.Results.10 (20.4%) of 49 eyes saved due to the combined chemotherapy. In 45 patients diseasefree survival rate was 56.1±8.9 % (with mean follow-up period 26.9±2.5 months). 1 of 45 patients died from leukemia. 44 of 45 patients are alive without metastasis. The mean follow-up was 20 months (3 to 43 months). Eye salvage rate in group C — 14 (93.3%) of 15, in group D — 31 (91.2%) of 34.Conclusion.These methods: second line of systemic chemotherapy, RT, and a Gamma Knife procedure should be considered as a failure of primary treatment. Our study demonstrated a high efficacy of local chemotherapy with promissing techniques of conservation therapy, which safety increases due to experience.

2 March 2021 in Malignant tumours
Verified
Journal Article
Open access
PDF file
ВБВ. В. Бредер
В. В. Бредер
ПБП. В. Балахнин
П. В. Балахнин
ЭВЭ. Р. Виршке
Э. Р. Виршке
ВКВ. Ю. Косырев
В. Ю. Косырев
ЕЛЕ. В. Ледин
Е. В. Ледин
VPVladislav Petkau
Vladislav Petkau
Практические рекомендации по лекарственному лечению больных гепатоцеллюлярным раком

15 February 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IKI. E. Khatkov
I. E. Khatkov
RAR. G. Avanesyan
R. G. Avanesyan
GAG. G. Akhaladze
G. G. Akhaladze
ABA. G. Beburishvili
A. G. Beburishvili
ABA. Yu. Bulanov
A. Yu. Bulanov
ЦВЦвиркун Виктор Викторович
Цвиркун Виктор Викторович
The research was performed at the Loginov Moscow Clinical Scientific Center. It is based on Russian obstructive jaundice (OJ) consensus results, considered at the 45th annual Central Research Institute of Gastroenterology Scientific session Oncological issues in the gastroenterologist practice (1 March 2019). The article objective is to note the diagnostic and conservative treatment current issues in patients with OJ. The increase in the number of patients with OJ of different etiology provides problem actuality. In a large number of cases, medical treatment is delayed due to inadequate diagnostic and management, while correct patients routing today can be provided regardless of medical institution level. In this article the examination steps and conservative treatment role in patients with biliary obstruction management are presented.

1 January 2018 in Transbaikalian Medical Bulletin
Verified
Journal Article
Closed access
БДБорис Иванович Долгушин
Борис Иванович Долгушин
ТУТатьяна Леонидовна Ушакова
Татьяна Леонидовна Ушакова
ИПИгорь Владимирович Погребняков
Игорь Владимирович Погребняков
ИТИгорь Александрович Трофимов
Игорь Александрович Трофимов
АКАндрей Всеволодович Кукушкин
Андрей Всеволодович Кукушкин
ВПВладимир Георгиевич Поляков
Владимир Георгиевич Поляков

9 September 2019 in Journal of radiology and nuclear medicine
Verified
Journal Article
Closed access
PDF file
MSM. A. Shorikov
M. A. Shorikov
OSO. N. Sergeeva
O. N. Sergeeva
AKA. V. Kashkadaeva
A. V. Kashkadaeva
SAS. G. Averinova
S. G. Averinova
MLM. G. Lapteva
M. G. Lapteva
ДФД. Ю. Францев
Д. Ю. Францев
Objective. To compare liver function assessments using Gd-EOB-DTPA-enhanced MRI and the gold standard hepatobiliary scintigraphy (HBS) in patients with bile duct diseases.Material and methods. The investigation enrolled 18 patients (male/female = 11/7; age, 29–70 years, Klatskin tumor (n=16), bile duct epithelial dysplasia (n=1), intrahepatic cholangiolithiasis (n=1)) after biliary decompression, who underwent 21 paired MRIs and 99mTc-mebrofenin HBS at a study interval of no more than 3 days. In the same regions of interest with a size of 30–50 pixels located in liver segments II–III, IV, V–VIII, and VI–VII, a MRI signal was measured before MR contrast agent (MRCA) injection into the standard vascular phases and at 10, 20, 30 and 40 minutes, then the signal was expressed as a percentage of intensity compared to the precontrast series. After MR volumetry, the functional volumes of the left and right liver lobes were also defined as the area under the MRCA accumulation curve, which was multiplied by the lobe volume and expressed as a percentage of the similarly calculated function of the entire liver. Similar intensity parameters and functional volumes were estimated for a HBS study.Results. The lobe functional volumes measured by the two methods were highly correlated (R=0.8; p0.3). The excretion rate of 99mTc-mebrofenin was also highly correlated with MRI findings (R=0.5–0.9; p<0.05).Conclusion. Gd-EOB-DTPA-enhanced MRI revealed a high correlation with the gold standard; however, additional studies are needed to clarify the possibilities and limitations of replacing one method with another one.

16 October 2023 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
EVE. R. Virshke
E. R. Virshke
IDI. A. Dzhanyan
I. A. Dzhanyan
IPI. V. Pogrebnyakov
I. V. Pogrebnyakov
VBV. V. Breder
V. V. Breder
MNM. S. Novruzbekov
M. S. Novruzbekov
BDB. I. Dolgushin
B. I. Dolgushin
Resection and orthotopic liver transplantation are considered radical methods in patients with hepatocellular cancer (HCC). However, recurrence is observed in 6-20 % of patients who have undergone liver transplantation for hepatocellular cancer. In about 20 % of cases there is an local lesion of the transplant, and a combination of intra- and extrahepatic metastasis is observed in at least 30 % of patients. At the time of detection of the recurrence of HCC in the liver transplant, most patients are no longer subject to radical treatment due to the presence of multifocal bilobar liver damage or extrahepatic metastasis. Transarterial chemoembolization (TACE) can be a method of choice, can make it possible long-term local control of the tumor process in the liver transplant.